What was recalled
This page covers AAFCO substantiation methodology rather than a specific recall event. AAFCO Nutrient Profiles establish minimum and (for some nutrients) maximum concentrations of protein, fat, vitamins, minerals, and amino acids in commercial dog and cat food. To be labeled "complete and balanced," pet food must demonstrate compliance with the appropriate AAFCO Nutrient Profile (dog or cat; growth/reproduction or adult maintenance). AAFCO permits two substantiation pathways. The formulated-to-meet method uses laboratory ingredient analysis (proximate analysis, mineral panels, vitamin panels) and calculates the finished food’s nutrient profile against AAFCO targets. Most commercial pet food in the U.S. uses this substantiation method.
The feeding trial method requires an 8-month minimum dog feeding study (or 6-month minimum cat feeding study) on a representative population of healthy dogs or cats. The study collects body weight, body condition score, hematology, serum biochemistry, and clinical observation data at study start, midpoint, and end. Test subjects must show no clinical signs of deficiency and acceptable maintenance of body condition. Hill’s Science Diet historically emphasized feeding-trial substantiation; Purina Pro Plan uses both methods across its portfolio; many premium-positioned and specialty brands use exclusively formulated-to-meet substantiation. The label distinction between "formulated to meet AAFCO Nutrient Profiles" vs "Animal feeding tests using AAFCO procedures substantiate" is a meaningful quality signal that many consumers do not recognize.
Why it was recalled
The two substantiation methods have different validation properties. Formulated-to-meet validates that the formulation’s laboratory-measured ingredient inputs, when combined per the recipe and assumed bioavailability, mathematically meet AAFCO Nutrient Profile targets. The method does not validate actual nutrient bioavailability in the finished food matrix, actual nutrient retention through thermal processing, actual digestibility in the target species, or actual clinical outcomes in feeding animals. The method is faster and less expensive than feeding trials but accepts assumed bioavailability rather than measured bioavailability.
Feeding trials validate clinical outcomes — they measure whether dogs or cats fed the formulation as their sole diet for 6-8 months maintain body weight, hematology, and serum biochemistry within healthy ranges. The method captures bioavailability, digestibility, and palatability simultaneously by measuring real-world physiological response. Feeding trials are substantially more expensive than formulated-to-meet substantiation ($100K-300K per trial vs single-digit thousands for laboratory analysis) and time-consuming (8 months minimum). The AVMA literature and AAFCO position note that feeding trials provide stronger evidence of nutritional adequacy than formulated-to-meet substantiation, though both methods are permitted by current regulation.
Health risks for your pet
Formulated-to-meet substantiation alone does not guarantee adequate clinical nutritional outcomes. The 2018-2023 grain-free DCM cardiomyopathy investigation surfaced one example: many of the grain-free formulations associated with FDA-investigated DCM cases were formulated-to-meet substantiated and met AAFCO Nutrient Profile calculations but were associated with adverse clinical outcomes in feeding pets. The taurine bioavailability and ingredient interactions that may have contributed to the DCM pattern were not captured by formulated-to-meet substantiation. Feeding-trial substantiated formulations carry stronger clinical-outcome validation but the trial design has known limitations: 6-8 month duration does not capture chronic effects over years, study populations are relatively small (8 dogs minimum, more for statistical power), and trial conditions do not capture all real-world feeding patterns.
What to do if you bought affected product
Pet owners can read AAFCO substantiation language on pet food labels. Labels stating "Animal feeding tests using AAFCO procedures substantiate that [Product] provides complete and balanced nutrition for [life stage]" indicate feeding-trial substantiation. Labels stating "[Product] is formulated to meet the nutritional levels established by the AAFCO [Cat/Dog] Food Nutrient Profiles for [life stage]" indicate formulated-to-meet substantiation. Both methods are AAFCO-permitted, but the feeding-trial language is a meaningful quality signal. For dogs and cats with special health considerations (kidney disease, cardiac disease, growth phases for large-breed puppies, performance dogs), the more rigorous feeding-trial substantiation is preferred where available. Brands using both methods across their portfolio (typically major manufacturers with the resources for feeding-trial programs) offer broader product validation than brands using exclusively formulated-to-meet substantiation.
How this affects KibbleIQ’s grade
AAFCO substantiation method is not yet a structural rubric input in KibbleIQ methodology v15 per our published methodology. Feeding-trial substantiation is being evaluated as a positive scoring factor for inclusion in methodology v2. The substantiation method choice is a meaningful brand-quality signal: feeding-trial substantiation requires investment in animal studies that demonstrates brand commitment to clinical-outcome validation beyond mathematical ingredient inputs. The 2018-2023 grain-free DCM investigation surfaced a real-world case where formulated-to-meet substantiation alone did not capture clinical-outcome risk; feeding-trial substantiation might have surfaced the formulation issues earlier in product development. Brands using feeding-trial substantiation for adult maintenance and growth life stages will receive favorable treatment under planned methodology v2.